bayer

FTC Clears Bayer's Purchase of Conceptus

The German drug company Bayer AG has received antitrust clearance from the Federal Trade Commission for its approximately $1.1 billion acquisition of Conceptus.

FDA Revisits Safety of Newer Birth Control Drugs

Birth control drugs that were heavily promoted as having fewer side effects are now under scrutiny from the FDA in the wake of new research suggesting that they are more likely to cause blood clots than older drugs.

Biz Brief: Micromet Stock Rises on Cancer Drug Trial Results

Micromet shares traded some 3.3% higher on Monday after the small-cap biotech announced that its candidate drug blinatumomab led to remission in almost four-fifths of leukemia patients in a Phase II trial. It also said that a Phase I trial showed the drug induced durable remission in patients with non-Hodgkin lymphoma.